Page 102 - Sitomegalovirüs Tanı, Tedavi Uzlaşı Raporu

with rheumatoid arthritis under treatment with an anti-IL-6 receptor antibody,
tocilizumab. Intern Med. 2016;55(14):1923-7.
124. Kawada J, Iwata N, Kitagawa Y, Kimura H, Ito Y. Prospective monitoring of Epstein-
Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated
with methotrexate and tocilizumab. Mod Rheumatol. 2012;22:565-570.
125. Mourgues C, Henquell C, Tatar Z, Pereira P, Nourisson C, Tournadre A, et al.
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus
(VZV) load in patients receiving tocilizumab for rheumatoid arthritis. Joint Bone Spine.
2016;83:412-415.
126. Yokogawa H, Kobayashi A, Yamazaki N, Sugiyama K. Identification of
cytomegalovirus and human herpesvirus-6 DNA in a patient with cornealendotheliitis.
Jpn J Ophthalmol. 2013;57(2):185-90.
127. Nakajima H, Takayama A, Ito T, Yoshikawa T. Acute encephalomyelitis with multiple
herpes viral reactivations during abatacept therapy. BMJ Case Rep. 2013;2013.
128. Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-
alpha antagonists on the course of chronic viral infections: a review of the literature.
Br J Dermatol. 2008;159(6):1217-28.
129. Kim SY, Solomon DH. Tumor necrosis factor blockade and the risk of viral infection.
Nat Rev Rheumatol. 2010;6:165-174.
130. Yanagisawa K, Ogawa Y, Hosogai M, Todokoro D, Mitsui T, Yokohama A, et al.
Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient
with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib
combinationtherapy. J Infect Chemother. 2017;23(8):572-575.
131. Tsai WP, Chen MH, Lee MH, Yu KH, Wu MW, Liou LB. Cytomegalovirus infection
causes morbidity and mortality in patients with autoimmune diseases, particularly
systemic lupus: in a Chinese population in Taiwan. Rheumatol Int. 2012;32(9):2901-
8.
132. Mohamed DF, Habeeb RA, Hosny SM, Ebrahim SE. Incidence and risk of infection in
egyptian patients with systemic lupus erythematosus. Clin Med Insights Arthritis
Musculoskelet Disord. 2014;7:41-8.
133. Xue Y, Jiang L, Wan WG, Chen YM, Zhang J, Zhang ZC. Cytomegalovirus
pneumonia in patients with rheumatic diseases after immunosuppressive therapy: a
single center study in China. Chin Med J (Engl). 2016;129(3):267-73.
134. Ren LM, Li Y, Zhang CF, Zhao XT, Liu X, Li ZG. Clinical characteristics and
associated risk factors of cytomegalovirus infection in patients with underlying
systemic Rheumatic diseases. Zhonghua Yi Xue Za Zhi. 2016;96(35):2772-2776.
135. Guidelines for prevention and treatment of opportunistic infections in HIV-infected
adults and adolescents. Recommendations from the Centers for Disease Control and
Prevention, the National Institutes of Health, and the HIV Medicine Association of the
Infectious Diseases Society of America. Downloaded from
http://aidsinfo.nih.gov/guidelines. 08.01.2015.
136. Kose S, Atalay S, Ulu Y, Sonmez U, Serin Senger S. The impact of BK virus and
Cytomegalovirus infections on graft in renal transplant patients: Experience of a
tertiary hospital in Turkey. Mediterr J Infect Microb Antimicrob. 2017;6:3.
137. R Hassan-Moosa, T Chinappa, L Jeena, L Visser, K Naidoo. Cytomegalovirus retinitis
and HIV: Case reviews from KwaZulu-Natal Province, South Africa. S Afr Med J.
2017;107(10):843-846.

99